Detection of imminent vein graft occlusion: what is the optimal surveillance program?
The prediction of infrainguinal vein bypass failure remains an inexact judgment. Patient demographics, technical factors, and vascular laboratory graft surveillance testing are helpful in identifying a high-risk graft cohort. The optimal surveillance program to detect the bypass at risk for imminent occlusion continues to be developed, but required elements are known and include clinical assessment for new or changes in limb ischemia symptoms, measurement of ankle and/or toe systolic pressure, and duplex ultrasound imaging of the bypass graft. Duplex ultrasound assessment of bypass hemodynamics may be the most accurate method to detect imminent vein graft occlusion. The finding of low graft flow during intraoperative assessment or at a scheduled surveillance study predicts failure; and if associated with an occlusive lesion, a graft revision can prolong patency. The most common abnormality producing graft failure is conduit stenosis caused by myointimal hyperplasia; and the majority can be repaired by an endovascular intervention. Frequency of testing to detect the failing bypass should be individualized to the patient, the type of arterial bypass, and prior duplex ultrasound scan findings. The focus of surveillance is on identification of the low-flow arterial bypass and timely repair of detected critical stenosis defined by duplex velocity spectra criteria of a peak systolic velocity 300 cm/s and peak systolic velocity ratio across the stenosis >3.5-correlating with >70% diameter-reducing stenosis. When conducted appropriately, a graft surveillance program should result in an unexpected graft failure rate of <3% per year.
Tinder
Chelsey N
CN
Division of Vascular and Endovascular Surgery, University of South Florida College of Medicine, Tampa, FL, USA.
Bandyk
Dennis F
DF
D000792:Angiography / Q000379:methods; D001783:Blood Flow Velocity / Q000187:drug effects / Q000502:physiology; D002985:Clinical Protocols; D006083:Graft Occlusion, Vascular / Q000000981:diagnostic imaging* / Q000517:prevention & control; D006801:Humans; D016343:Monitoring, Intraoperative / Q000379:methods; D012016:Reference Values; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D018616:Ultrasonography, Doppler, Duplex / Q000379:methods; D014654:Vascular Patency